LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma ; volume:22 ; number:1 ; day:10 ; month:11 ; year:2022 ; pages:1-13 ; date:12.2022
BMC pulmonary medicine ; 22, Heft 1 (10.11.2022), 1-13, 12.2022
- Creator
-
Wang, Junbin
Liu, Jixian
Hou, Qinghua
Xu, Mengmeng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-022-02215-4
- URN
-
urn:nbn:de:101:1-2023012422163637339727
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Junbin
- Liu, Jixian
- Hou, Qinghua
- Xu, Mengmeng
- SpringerLink (Online service)
Other Objects (12)
SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung
Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung
Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Immunotherapeutic approach to a case of advanced hepatoid adenocarcinoma of the lung
Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases